Cereno Scientific AB (publ) reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was SEK 17.42 million compared to SEK 20.98 million a year ago. Revenue was SEK 17.42 million compared to SEK 20.98 million a year ago. Net loss was SEK 21.93 million compared to SEK 8.64 million a year ago. Basic loss per share from continuing operations was SEK 0.09 compared to SEK 0.06 a year ago.
For the full year, sales was SEK 49.28 million compared to SEK 57.54 million a year ago. Revenue was SEK 49.28 million compared to SEK 57.54 million a year ago. Net loss was SEK 48.11 million compared to SEK 27.65 million a year ago. Basic loss per share from continuing operations was SEK 0.21 compared to SEK 0.2 a year ago.